Uterus transplant could help many women fulfil the desire to have a child, as this is a tremendous driving force for many women, especially who cannot bear children because of a malfunctioning uterus. Doctors in a New York hospital are planning the first uterus transplant and are screening women who would have a chance to bear children.
Scientists at ProXara Biotechnology Limited have identified a way of switching off one of the key mechanisms that leads to the development and growth of a tumour. Under the Wellcome Trust’s Seeding Drug Discovery initiative, the researchers hope to use their findings to develop a drug that could be used to fight cancer. The funding will be used to develop the drug to a point at which it is close to entering a clinical trial.
Surveyors of anti-aging elixirs tout human growth hormone as a remedy for all things sagging-from skin to libidos — and claim it can even prevent or reverse aging. But researchers at the Stanford University School of Medicine say there’s no evidence to suggest that this purported fountain of youth has any more effect than a trickle of tap water when it comes to fending off Father Time.
Scientists at the Wellcome Trust Center for Neuroimaging, University College London, have shown that people with damage to the hippocampus, the area of the brain that plays a crucial role in learning and memory, not only have trouble remembering the past but also in imagining new and future experiences.
Cloudy apple juice has four times the concentration of polyphenols (chemicals reported to have anti-cancer activity) than clear. Tasty orange sausages with 60 percent reduced fat and added dietary fiber. Learn about the science behind the perfect espresso.
University of Minnesota stem cell researchers, together with collaborators at Stanford University, have successfully used adult stem cells to replace the immune system and bone marrow of mice, offering the promise of new therapies for people in the future.
An international effort led by scientists at the University of Toronto, Columbia University and Boston University has isolated another gene responsible for Alzheimer’s disease.
Roslin scientists, Roslin Institute – Scotland UK, have created the world’s first breed of genetically modified chickens to lay eggs capable of producing drugs that fight cancer and other life-threatening diseases.
Variations in a gene known as SORL1 may be a factor in the development of late onset Alzheimer’s disease, an international team of researchers has discovered. The genetic clue, which could lead to a better understanding of one cause of Alzheimer’s, is reported in Nature Genetics online, Jan. 14, 2007, and was supported in part by the National Institutes of Health.
An international team of researchers, led by Columbia University Medical Center, Boston University School of Medicine and the University of Toronto, has uncovered a major new gene — SORL1 — implicated in late-onset Alzheimer’s disease. Replicated in four distinct ethnic groups, SORL1 is only the second genetic variant for late-onset Alzheimer’s, the type of Alzheimer’s found in 90 percent of people with this devastating disease. ApoE4, the first, was identified in 1993.